InheRET empowering individuals to accurately identify their risk for hereditary conditions.
InheRET has raised $580K in total funding. The most recent round was Seed. The last funding was announced in May 2022.
InheRET's investors include National Cancer Institute, Accelerate Blue Fund.
InheRET is headquartered in Ann Arbor, United States.
InheRET empowering individuals to accurately identify their risk for hereditary conditions.
InheRET is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InheRET — Funding & Investors." VCBacked, May 2, 2022, https://www.vcbacked.co/company/inheret. Accessed September 14, 2026.
VCBacked. (2022). InheRET — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/inheret
{{cite web |title=InheRET — Funding & Investors |url=https://www.vcbacked.co/company/inheret |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated